Longer Revlimid Maintenance after Stem Cell Transplant Prolongs Myeloma Patient Survival
Longer duration of maintenance therapy with Revlimid (lenalidomide) after autologous hematopoietic stem cell transplantation (HSCT) prolongs survival for multiple myeloma patients without increasing…